Sygnature takes immense pride in its numerous accomplishments, fruitful research partnerships, and well-deserved awards. It is with great pleasure that we share these remarkable achievements at every available opportunity. Contained herein, you will have the opportunity to explore and be informed about the latest and most thrilling advancements taking place within our organization.
Filter by:
17th December 2021
News
Expansions, transactions and all action: Our 2021 recap!
30th November 2021
News
New CFO Jordison steps up
20th August 2021
News
Sygnature and Epigeneron, the Japanese Bio-Venture, Join Forces in Collaboration
29th June 2021
Drug Discovery News
Five Arrows invests in Sygnature Discovery
16th June 2021
Drug Discovery News
Sygnature Discovery’s Early CMC Development Expansion: Unveiling New Opportunities
20th May 2021
News
Sygnature gains ISO:27001 certification for information security
6th May 2021
News
Sygnature appoints Dr David Lustig to spearhead US expansion
27th April 2021
Drug Discovery News
Sygnature Discovery expands US presence with Bay Area office
1st April 2021
News
Legendary Werewolf: A Freak Chemistry Accident at Sygnature!
25th March 2021
DMPK in vivo pharmacology News
Leading UK Drug Discovery CROs Unite as Sygnature Discovery
18th February 2021
Drug Discovery News
Sygnature Discovery Opens Second Drug Discovery Site at Alderley Park
10th February 2021
Blog Events News
Powerful Webinar Series Unites Sygnature and Altasciences